Evolent Health (NYSE:EVH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $0.34 by 179.41 percent. The company reported quarterly sales of $621.400 million which missed the analyst consensus estimate of $627.151 million by 0.92 percent. This is a 21.60 percent increase over sales of $511.015 million the same period last year.